Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Supporters often emphasize the potential for substantial therapeutic gains, especially in diseases where conventional treatments have proven inadequate. However, crucially important to evaluate the significant financial expenditure associated with